Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Enns
Robert
R
Division of Gastroenterology, Department of Medicine, St Paul's Hospital, University of British Columbia, Vancouver, BC, V6K 2A5 Canada. renns@interchange.ubc.ca
Andrews
Christopher N
CN
Fishman
Martin
M
Hahn
Michael
M
Atkinson
Kenneth
K
Kwan
Peter
P
Levy
Adrian
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D016099:Endoscopy, Gastrointestinal; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000077402:Pantoprazole; D010818:Practice Patterns, Physicians'; D012189:Retrospective Studies; D013454:Sulfoxides / Q000008:administration & dosage / Q000627:therapeutic use*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D013454:Sulfoxides; D000077402:Pantoprazole; D009853:Omeprazole